CVRx, Inc. (CVRX) Insider Trading
Over the last 3 months, CVRX insiders made 0 open-market buys and 1 sale, a net sale of -$10K (SEC Form 4). Over the last 6 months, 66 institutions increased and 54 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
1
Net (3m)
-$10.0K
Insider trades by month Buys Sells
May
Nov
Dec
Jan
Feb
Mar
Context3-month price -29.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 3, 2026 | SLATTERY JOSEPH Pdirector | Grant | 11,182 | $5.43 |
| Jun 3, 2026 | Hill, Mitch C.director | Grant | 11,182 | $5.43 |
| Jun 3, 2026 | Hill, Mitch C.director | Grant | 8,720 | — |
| Jun 3, 2026 | Ballinger Kevin J.director | Grant | 8,720 | — |
| Jun 3, 2026 | Ballinger Kevin J.director | Grant | 11,182 | $5.43 |
| Jun 3, 2026 | SHADAN MARTHAdirector | Grant | 8,720 | — |
| Jun 3, 2026 | SHADAN MARTHAdirector | Grant | 11,182 | $5.43 |
| Jun 3, 2026 | DALE MICHAEL Ddirector | Grant | 29,005 | — |
| Jun 3, 2026 | DALE MICHAEL Ddirector | Grant | 36,252 | $5.43 |
| Jun 3, 2026 | Nielsen Kirk G.director | Grant | 8,720 | — |
| Jun 3, 2026 | Nielsen Kirk G.director | Grant | 11,182 | $5.43 |
| Jun 3, 2026 | Jain Mudit K.director | Grant | 8,720 | — |
| Jun 3, 2026 | Jain Mudit K.director | Grant | 11,182 | $5.43 |
| Jun 3, 2026 | SLATTERY JOSEPH Pdirector | Grant | 8,720 | — |
| Mar 16, 2026 | Adamson Philip B.officer: Chief Medical Officer | Grant | 41,000 | — |
| Mar 16, 2026 | Adamson Philip B.officer: Chief Medical Officer | Sell | 1,262 | $7.90 |
| Mar 16, 2026 | Adamson Philip B.officer: Chief Medical Officer | Grant | 62,000 | $8.16 |
| Mar 4, 2026 | Morrison Gregoryofficer: CHIEF HUMAN RESOURCES OFFICER | Grant | 34,000 | — |
| Mar 4, 2026 | Morrison Gregoryofficer: CHIEF HUMAN RESOURCES OFFICER | Grant | 154,500 | $8.22 |
| Mar 3, 2026 | OASHEIM JAREDofficer: CHIEF FINANCIAL OFFICER | Grant | 91,000 | $8.16 |
| Mar 3, 2026 | OASHEIM JAREDofficer: CHIEF FINANCIAL OFFICER | Sell | 1,744 | $7.90 |
| Mar 3, 2026 | OASHEIM JAREDofficer: CHIEF FINANCIAL OFFICER | Grant | 61,000 | — |
| Mar 3, 2026 | VERRASTRO PAULofficer: CHIEF MKTG & STRAT OFFICER | Grant | 67,000 | $8.16 |
| Mar 3, 2026 | VERRASTRO PAULofficer: CHIEF MKTG & STRAT OFFICER | Grant | 45,000 | — |
| Mar 3, 2026 | VERRASTRO PAULofficer: CHIEF MKTG & STRAT OFFICER | Sell | 1,284 | $7.90 |
| Mar 3, 2026 | Hykes Kevindirector, officer: PRES & CEO | Grant | 238,000 | $8.16 |
| Mar 3, 2026 | Hykes Kevindirector, officer: PRES & CEO | Sell | 7,763 | $7.90 |
| Mar 3, 2026 | Hykes Kevindirector, officer: PRES & CEO | Grant | 159,000 | — |
| Mar 3, 2026 | Binkowski Brentofficer: CHIEF OPERATING OFFICER | Grant | 23,000 | $8.16 |
| Mar 3, 2026 | Binkowski Brentofficer: CHIEF OPERATING OFFICER | Grant | 15,000 | — |
Source: CVRX SEC Form 4 filings, latest Jun 3, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their CVRX positions over the last 6 months (SEC Form 13F).
Increased
66
New positions
31
Reduced
54
Sold out
21
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| JOHNSON & JOHNSON | Unchanged | 4.0M | May 13, 2026 |
| JOHNSON & JOHNSON | Reduced | 4.0M | Mar 18, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 2.0M | Feb 17, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 2.0M | May 15, 2026 |
| VANGUARD GROUP INC | Increased | 1.1M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 1.1M | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 1.0M | May 13, 2026 |
| GSK PLC | Unchanged | 1.0M | May 14, 2026 |
| GSK PLC | New Position | 1.0M | Feb 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 911K | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 815K | Feb 17, 2026 |
| ROYAL BANK OF CANADA | Increased | 707K | May 15, 2026 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | Increased | 635K | Feb 17, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Reduced | 631K | May 15, 2026 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | Reduced | 572K | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.